TRANSFORMS PAINT INTO A HIGHLY EFFECTIVE ANTI-PATHOGENIC COATING
Paint additive to create anti-pathogenic surface coatings with traceable protection: tested against bacteria, enveloped and non-enveloped viruses.
When contact-tested with SARS-Cov-2, the COVID-19 virus, Retrace AV proved 99.99% effective within 30 minutes.
Covert, scannable technology to prove product authenticity, origination or levels of protection.
The success of our pioneering products is a direct reflection of the knowledge and experience of our carefully assembled team and extended scientific network. We have forged strong relationships and collaborations with leading scientific institutions and universities in the UK and overseas that provide us with a highly qualified team of scientists to complement our in-house expertise in a number of fields and specialisms.
Retrace Group is a true innovator: engaged in redefining the authentication of surfaces and manufacturing materials to better protect the places in which we all work and live. Through a combination of rigorous R&D and the application of deep scientific expertise, underpinned at every stage by internationally recognised testing, we create products that greatly enhance the health and safety of a myriad of built environments, and the traceability and authentication of manufacturing materials. To ensure our focus remains on the fresh thinking, applied science and technological innovation behind our products, we enter into relationships with world leading companies to manufacture, distribute and take our products to market in countries around the world.